| Financial Year |
March 31 2023 |
| Monetary Funds |
897,745,389.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
279,839,560.44 |
| Advances to Suppliers |
25,588,342.78 |
| Other Receivables |
6,514,815.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
331,531,906.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
99,396,268.88 |
| Total Current Assets |
1,986,603,136.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,793,537.04 |
| Investment Properties |
-- |
| Fixed Assetes |
686,364,607.56 |
| Under-construction Projects |
1,003,670,467.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,813,086.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
8,290,785.15 |
| Other Non-Current Assets |
22,746,067.26 |
| Sub-Total of Non-Current Assets |
1,871,678,550.82 |
| Total Assets |
3,858,281,687.01 |
| Short-Term Loans |
110,159,194.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
349,448,090.80 |
| Accounts Payable |
342,864,773.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,081,203.11 |
| Taxes Payable |
12,555,451.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,939,897.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,555,822.16 |
| Sub-Total of Current Liabilities |
889,931,220.26 |
| Long-term Loans |
-- |
| Bonds Payable |
548,691,743.32 |
| Long-Term Accounts Payable |
72,210,396.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,272,717.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
674,243,769.27 |
| Total Liabilities |
1,564,174,989.53 |
| Paid-In Capital(Or Share Stock) |
185,482,000.00 |
| Capital Surplus |
523,940,767.92 |
| Surplus Reserve |
92,313,850.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,222,530,481.42 |
| Minority Stockholder's Interest |
160,958,746.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,133,147,951.04 |
| Owner's Equity（Stockholder's Equity） |
2,294,106,697.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,858,281,687.01 |
